European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)Mical Paul, Jesús Rodríguez‐Baño, Elena Carrara et al.|Clinical Microbiology and Infection|2021Cited by 1k
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing EnterobacteriaceaeJesús Rodríguez‐Baño, Álvaro Pascual|Clinical Microbiology Reviews|2018Cited by 688
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez‐Gutiérrez, Mario Fernández‐Ruiz, Álvaro Pascual et al.|The Lancet Infectious Diseases|2017Cited by 521
Rationalizing antimicrobial therapy in the ICU: a narrative reviewJean‐François Timsit, François Barbier, Matteo Bassetti et al.|Intensive Care Medicine|2019Cited by 266
Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistanceJan J. De Waele, Matteo Bassetti, Murat Akova et al.|Intensive Care Medicine|2017Cited by 184